Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||0.26%||82.48||0.7%||$1558.96m|
|JNJ||Johnson & Johnson||-0.01%||165.76||0.7%||$1044.55m|
|LLY||Eli Lilly & Co.||0.51%||249.74||1.1%||$642.36m|
|BMY||Bristol-Myers Squibb Co.||0.00%||58.21||1.0%||$634.93m|
|AVIR||Atea Pharmaceuticals, Inc.||-0.08%||12.38||0.3%||$123.37m|
|NVO||Novo Nordisk A/S||-1.33%||105.95||0.1%||$89.64m|
|OGN||Organon & Co.||-0.33%||36.62||0.0%||$52.99m|
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.